Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 145

1.

Processing of different spatial scales in the human brain.

Peer M, Ron Y, Monsa R, Arzy S.

Elife. 2019 Sep 10;8. pii: e47492. doi: 10.7554/eLife.47492.

2.

Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a retrospective national multi-center study.

Bentur OS, Dann EJ, Paran E, Lavie D, Nachmias B, Ron Y, Dally N, Gutwein O, Herishanu Y, Sarid N, Avivi I, Perry C.

Ann Hematol. 2019 Jul;98(7):1665-1674. doi: 10.1007/s00277-019-03686-y. Epub 2019 May 18.

PMID:
31104090
3.

Psychodrama's Role in Alleviating Acute Distress: A Case Study of an Open Therapy Group in a Psychiatric Inpatient Ward.

Ron Y.

Front Psychol. 2018 Oct 30;9:2075. doi: 10.3389/fpsyg.2018.02075. eCollection 2018.

4.

Evaluation of a new pan-enteric video capsule endoscopy system in patients with suspected or established inflammatory bowel disease - feasibility study.

Eliakim R, Spada C, Lapidus A, Eyal I, Pecere S, Fernández-Urién I, Lahat A, Costamagna G, Schwartz A, Ron Y, Yanai H, Adler S.

Endosc Int Open. 2018 Oct;6(10):E1235-E1246. doi: 10.1055/a-0677-170. Epub 2018 Oct 8.

5.

Evaluation of ocular motility deviation changes in exotropic patients after cycloplegic eye drops versus prism adaptation test.

Zahavi A, Friling R, Ron Y, Ehrenberg M, Nahum Y, Snir M.

Eur J Ophthalmol. 2019 Sep;29(5):482-485. doi: 10.1177/1120672118803518. Epub 2018 Oct 4.

PMID:
30284456
6.

Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls.

Hod K, Sperber AD, Maharshak N, Ron Y, Shapira I, David Z, Rogowski O, Berliner S, Shenhar-Tsarfaty S, Dekel R.

Neurogastroenterol Motil. 2018 Dec;30(12):e13464. doi: 10.1111/nmo.13464. Epub 2018 Sep 21.

PMID:
30240124
7.

Effectiveness and safety of vedolizumab for maintenance treatment in inflammatory bowel disease-The Israeli real world experience.

Kopylov U, Avni-Biron I, Ron Y, Koslowsky B, Waterman M, Daher S, Ungar B, Schwartz D, Zittan E, Openhaim M, Yanai H, Maharshak N, Bar Gil Shitrit A, Naftali T, Eliakim R, Chowers Y, Ben-Horin S, Dotan I.

Dig Liver Dis. 2019 Jan;51(1):68-74. doi: 10.1016/j.dld.2018.07.040. Epub 2018 Aug 10.

PMID:
30172649
8.

The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.

Hod K, Dekel R, Aviv Cohen N, Sperber A, Ron Y, Boaz M, Berliner S, Maharshak N.

Neurogastroenterol Motil. 2018 Dec;30(12):e13456. doi: 10.1111/nmo.13456. Epub 2018 Aug 23.

PMID:
30136337
9.

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease-A Multicenter Retrospective European Study.

Kopylov U, Verstockt B, Biedermann L, Sebastian S, Pugliese D, Sonnenberg E, Steinhagen P, Arebi N, Ron Y, Kucharzik T, Roblin X, Ungar B, Shitrit AB, Ardizzone S, Molander P, Coletta M, Peyrin-Biroulet L, Bossuyt P, Avni-Biron I, Tsoukali E, Allocca M, Katsanos K, Raine T, Sipponen T, Fiorino G, Ben-Horin S, Eliakim R, Armuzzi A, Siegmund B, Baumgart DC, Kamperidis N, Maharshak N, Maaser C, Mantzaris G, Yanai H, Christodoulou DK, Dotan I, Ferrante M.

Inflamm Bowel Dis. 2018 Oct 12;24(11):2442-2451. doi: 10.1093/ibd/izy155.

PMID:
29788318
10.

Novel prep-less X-ray imaging capsule for colon cancer screening: a feasibility study.

Gluck N, Half EE, Bieber V, Schwartz D, Ron Y, Gralnek I, Klein A, Lachter J, Levy MS, Moshkowitz M, Arber N.

Gut. 2019 May;68(5):774-775. doi: 10.1136/gutjnl-2018-316127. Epub 2018 May 21. No abstract available.

PMID:
29785966
11.

Management of severe persistent fetal vasculature: case series and review of the literature.

Zahavi A, Weinberger D, Snir M, Ron Y.

Int Ophthalmol. 2019 Mar;39(3):579-587. doi: 10.1007/s10792-018-0855-9. Epub 2018 Feb 23. Review.

PMID:
29476279
12.

[THE ISRAELI NEUROGASTROENTEROLOGY ASSOCIATION RECOMMENDATIONS FOR THE EVALUATION AND TREATMENT OF CHRONIC CONSTIPATION].

Carter D, Ron Y, Dickman R.

Harefuah. 2017 Nov;156(11):725-729. Review. Hebrew.

PMID:
29198092
13.

Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies.

Icht O, Yanai H, Ron Y, Rosner G, Yaron A, Waizbard A, Ziv-Baran T, Fishman S, Dotan I.

Digestion. 2017;96(3):135-141. doi: 10.1159/000477438. Epub 2017 Aug 26.

PMID:
28848118
14.

A double-blind, placebo-controlled study to assess the effect of a probiotic mixture on symptoms and inflammatory markers in women with diarrhea-predominant IBS.

Hod K, Sperber AD, Ron Y, Boaz M, Dickman R, Berliner S, Halpern Z, Maharshak N, Dekel R.

Neurogastroenterol Motil. 2017 Jul;29(7). doi: 10.1111/nmo.13037. Epub 2017 Mar 8.

PMID:
28271623
15.

Adolescent transition clinic in inflammatory bowel disease: quantitative assessment of self-efficacy skills.

Yerushalmy-Feler A, Ron Y, Barnea E, Nachum A, Matalon S, Dali-Levy M, Dotan I, Cohen S.

Eur J Gastroenterol Hepatol. 2017 Jul;29(7):831-837. doi: 10.1097/MEG.0000000000000864.

PMID:
28230561
16.

Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.

Kopylov U, Ron Y, Avni-Biron I, Koslowsky B, Waterman M, Daher S, Ungar B, Yanai H, Maharshak N, Ben-Bassat O, Lichtenstein L, Bar-Gil Shitrit A, Israeli E, Schwartz D, Zittan E, Eliakim R, Chowers Y, Ben-Horin S, Dotan I.

Inflamm Bowel Dis. 2017 Mar;23(3):404-408. doi: 10.1097/MIB.0000000000001039.

PMID:
28178003
17.

Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis.

Ungar B, Mazor Y, Weisshof R, Yanai H, Ron Y, Goren I, Waizbard A, Yavzori M, Fudim E, Picard O, Loebstein R, Kopylov U, Dotan I, Chowers Y, Eliakim R, Ben-Horin S.

Aliment Pharmacol Ther. 2016 Jun;43(12):1293-9. doi: 10.1111/apt.13631. Epub 2016 Apr 19.

18.

Ultrasonographic demonstration of the superior ophthalmic vein in the orbit of premature infants with and without retinopathy of prematurity.

Ron Y, Barash D, Erhenberg M, Friling R, Osovsky M, Sirota L, Snir M, Ehrlich R.

Med Hypotheses. 2015 Nov;85(5):565-7. doi: 10.1016/j.mehy.2015.07.024. Epub 2015 Aug 5.

PMID:
26275364
19.

Effects of Sacral Neuromodulation on Urinary and Fecal Incontinence.

Rosen A, Taragano L, Condrea A, Sidi A, Ron Y, Ginath S.

Isr Med Assoc J. 2015 Jun;17(6):351-5.

20.

Infliximab-Related Infusion Reactions: Systematic Review.

Lichtenstein L, Ron Y, Kivity S, Ben-Horin S, Israeli E, Fraser GM, Dotan I, Chowers Y, Confino-Cohen R, Weiss B.

J Crohns Colitis. 2015 Sep;9(9):806-15. doi: 10.1093/ecco-jcc/jjv096. Epub 2015 Jun 19. Review.

21.

Significance of low level infliximab in the absence of anti-infliximab antibodies.

Ungar B, Anafy A, Yanai H, Ron Y, Yavzori M, Picard O, Fudim E, Loebstein R, Kopylov U, Chowers Y, Dotan I, Eliakim R, Ben-Horin S.

World J Gastroenterol. 2015 Feb 14;21(6):1907-14. doi: 10.3748/wjg.v21.i6.1907.

22.

Safety and efficacy of the vibrating capsule, an innovative non-pharmacological treatment modality for chronic constipation.

Ron Y, Halpern Z, Safadi R, Dickman R, Dekel R, Sperber AD.

Neurogastroenterol Motil. 2015 Jan;27(1):99-104. doi: 10.1111/nmo.12485. Epub 2014 Dec 6.

PMID:
25484196
23.

Patient factors that increase infliximab clearance and shorten half-life in inflammatory bowel disease: a population pharmacokinetic study.

Dotan I, Ron Y, Yanai H, Becker S, Fishman S, Yahav L, Ben Yehoyada M, Mould DR.

Inflamm Bowel Dis. 2014 Dec;20(12):2247-59. doi: 10.1097/MIB.0000000000000212.

PMID:
25358062
24.

Levels of drug and antidrug antibodies are associated with outcome of interventions after loss of response to infliximab or adalimumab.

Yanai H, Lichtenstein L, Assa A, Mazor Y, Weiss B, Levine A, Ron Y, Kopylov U, Bujanover Y, Rosenbach Y, Ungar B, Eliakim R, Chowers Y, Shamir R, Fraser G, Dotan I, Ben-Horin S.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):522-530.e2. doi: 10.1016/j.cgh.2014.07.029. Epub 2014 Jul 25.

PMID:
25066837
25.

Inflammatory monocytes orchestrate innate antifungal immunity in the lung.

Espinosa V, Jhingran A, Dutta O, Kasahara S, Donnelly R, Du P, Rosenfeld J, Leiner I, Chen CC, Ron Y, Hohl TM, Rivera A.

PLoS Pathog. 2014 Feb 20;10(2):e1003940. doi: 10.1371/journal.ppat.1003940. eCollection 2014 Feb.

26.

Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication.

Miller LK, Kobayashi Y, Chen CC, Russnak TA, Ron Y, Dougherty JP.

Retrovirology. 2013 Oct 24;10:120. doi: 10.1186/1742-4690-10-120.

27.

Isolation of multilineage progenitors from mouse brain.

Chen CC, Huang HI, Louis CL, Lin KT, Ron Y.

In Vitro Cell Dev Biol Anim. 2013 May;49(5):307-14. doi: 10.1007/s11626-013-9625-1. Epub 2013 May 1.

PMID:
23636940
28.

Prevalence of symptoms suggestive of gastroparesis in a cohort of patients with diabetes mellitus.

Dickman R, Kislov J, Boaz M, Ron Y, Beniashvili Z, Raz I, Baigel I, Niv Y, Wainstein J.

J Diabetes Complications. 2013 Jul-Aug;27(4):376-9. doi: 10.1016/j.jdiacomp.2013.02.004. Epub 2013 Mar 16.

PMID:
23507560
29.

Ensure preparation and capsule endoscopy: a two-center prospective study.

Niv E, Ovadia B, Ron Y, Santo E, Mahajna E, Halpern Z, Fireman Z.

World J Gastroenterol. 2013 Feb 28;19(8):1264-70. doi: 10.3748/wjg.v19.i8.1264.

30.

Comparison of continuous breath test and gastric scintigraphy for the measurement of gastric emptying rate in healthy and dyspeptic individuals.

Dickman R, Zilper T, Steinmetz A, Pakanaev L, Ron Y, Bernstine H, Groshar D, Niv Y, Shirin H.

Eur J Gastroenterol Hepatol. 2013 Mar;25(3):291-5. doi: 10.1097/MEG.0b013e32835c075d.

PMID:
23354159
31.

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response.

Katz L, Gisbert JP, Manoogian B, Lin K, Steenholdt C, Mantzaris GJ, Atreja A, Ron Y, Swaminath A, Shah S, Hart A, Lakatos PL, Ellul P, Israeli E, Svendsen MN, van der Woude CJ, Katsanos KH, Yun L, Tsianos EV, Nathan T, Abreu M, Dotan I, Lashner B, Brynskov J, Terdiman JP, Higgins PD, Chaparro M, Ben-Horin S.

Inflamm Bowel Dis. 2012 Nov;18(11):2026-33. doi: 10.1002/ibd.22902. Epub 2012 Jan 31.

32.

The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD.

Ben-Horin S, Mazor Y, Yanai H, Ron Y, Kopylov U, Yavzori M, Picard O, Fudim E, Maor Y, Lahat A, Coscas D, Eliakim R, Dotan I, Chowers Y.

Aliment Pharmacol Ther. 2012 Mar;35(6):714-22. doi: 10.1111/j.1365-2036.2012.04997.x. Epub 2012 Jan 30.

33.

Assessment of high-sensitivity CRP as a marker of micro-inflammation in irritable bowel syndrome.

Hod K, Dickman R, Sperber A, Melamed S, Dekel R, Ron Y, Halpern Z, Berliner S, Maharshak N.

Neurogastroenterol Motil. 2011 Dec;23(12):1105-10. doi: 10.1111/j.1365-2982.2011.01788.x. Epub 2011 Sep 26.

PMID:
21951717
34.

Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol.

Snir M, Reich U, Siegel R, Zvulunov A, Friling R, Goldenberg-Cohen N, Ron Y, Ben-Amitay D.

Eye (Lond). 2011 Dec;25(12):1627-34. doi: 10.1038/eye.2011.233. Epub 2011 Sep 16.

35.

Post-transcriptionally regulated expression system in human xenogeneic transplantation models.

Lee HL, Chen CC, Baasov T, Ron Y, Dougherty JP.

Mol Ther. 2011 Sep;19(9):1645-55. doi: 10.1038/mt.2011.90. Epub 2011 May 17.

36.

Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity.

Axer-Siegel R, Snir M, Ron Y, Friling R, Sirota L, Weinberger D.

Retina. 2011 Jul-Aug;31(7):1239-47. doi: 10.1097/IAE.0b013e31820d4000.

PMID:
21555969
37.

High-throughput screening uncovers a compound that activates latent HIV-1 and acts cooperatively with a histone deacetylase (HDAC) inhibitor.

Micheva-Viteva S, Kobayashi Y, Edelstein LC, Pacchia AL, Lee HL, Graci JD, Breslin J, Phelan BD, Miller LK, Colacino JM, Gu Z, Ron Y, Peltz SW, Dougherty JP.

J Biol Chem. 2011 Jun 17;286(24):21083-91. doi: 10.1074/jbc.M110.195537. Epub 2011 Apr 15.

38.

Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid.

Krause CD, Izotova LS, Ren G, Yuan ZR, Shi Y, Chen CC, Ron Y, Pestka S.

Stem Cell Res Ther. 2011 Mar 14;2(2):15. doi: 10.1186/scrt56.

39.

Early satiety is the only patient-reported symptom associated with delayed gastric emptying, as assessed by breath-test.

Ron Y, Sperber AD, Levine A, Shevah O, Dickman R, Avni Y, Shirin H.

J Neurogastroenterol Motil. 2011 Jan;17(1):61-6. doi: 10.5056/jnm.2011.17.1.61. Epub 2011 Jan 26.

40.

Long-term ophthalmological follow-up of children with Parinaud syndrome.

Goldenberg-Cohen N, Haber J, Ron Y, Kornreich L, Toledano H, Snir M, Cohen IJ, Michowiz S.

Ophthalmic Surg Lasers Imaging. 2010 Jul-Aug;41(4):467-71. doi: 10.3928/15428877-20100426-02.

PMID:
20438046
41.

Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphoma.

Fan G, Simmons MJ, Ge S, Dutta-Simmons J, Kucharczak J, Ron Y, Weissmann D, Chen CC, Mukherjee C, White E, Gélinas C.

Blood. 2010 Apr 29;115(17):3559-69. doi: 10.1182/blood-2009-08-236760. Epub 2010 Feb 25.

42.

Cross-reactive antibodies induced by xenogeneic IgA can cause selective IgA deficiency.

Klartag A, Chen CC, Dougherty JP, Ron Y.

Autoimmunity. 2010 Mar;43(2):164-71. doi: 10.3109/08916930903277329.

PMID:
19824874
43.

In vivo post-transcriptional regulation of CD154 in mouse CD4+ T cells.

Vavassori S, Shi Y, Chen CC, Ron Y, Covey LR.

Eur J Immunol. 2009 Aug;39(8):2224-32. doi: 10.1002/eji.200839163.

44.

Molecular characterization of newly identified IS3, IS4 and IS30 insertion sequence-like elements in Mycoplasma bovis and their possible roles in genome plasticity.

Lysnyansky I, Calcutt MJ, Ben-Barak I, Ron Y, Levisohn S, Methé BA, Yogev D.

FEMS Microbiol Lett. 2009 May;294(2):172-82. doi: 10.1111/j.1574-6968.2009.01562.x.

45.

Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: inhibition by an anti-osteopontin monoclonal antibody.

Wang KX, Shi YF, Ron Y, Kazanecki CC, Denhardt DT.

J Immunol. 2009 Feb 15;182(4):2485-91. doi: 10.4049/jimmunol.0803023.

46.

Z-tenotomy of the superior oblique tendon and horizontal rectus muscle surgery for A-pattern horizontal strabismus.

Ron Y, Snir M, Axer-Seigel R, Friling R.

J AAPOS. 2009 Feb;13(1):27-30. doi: 10.1016/j.jaapos.2008.09.004. Epub 2008 Dec 12.

PMID:
19084442
47.

The etiology of V pattern strabismus in patients with craniosynostosis.

Ron Y, Dagi LR.

Int Ophthalmol Clin. 2008 Spring;48(2):215-23. doi: 10.1097/IIO.0b013e3181695af6. Review. No abstract available.

PMID:
18427272
48.

[New horizons in the treatment of fecal incontinence].

Zmora O, Tulchinsky H, Ron Y.

Harefuah. 2007 Oct;146(10):776-80, 813. Review. Hebrew.

PMID:
17990393
49.

"Competitive quenching": a mechanism by which perihydroxylated perylenequinone photosensitizers can prevent adverse phototoxic damage caused by verteporfin during photodynamic therapy.

Lavie G, Barliya T, Mandel M, Blank M, Ron Y, Orenstein A, Livnat T, Friedman N, Weiner L, Sheves M, Weinberger D.

Photochem Photobiol. 2007 Sep-Oct;83(5):1270-7.

PMID:
17880523
50.

[Eating and swallowing disorders in children].

Ben David N, Ron Y, Mandelberg A, Levine A, Flacksman C, Russo E, Roth Y.

Harefuah. 2007 Feb;146(2):95-8, 167. Hebrew.

PMID:
17352275

Supplemental Content

Support Center